InfraScan specializes in the development and commercialization of a portable brain scanner that utilizes Near-Infrared (NIR) technology for the assessment of head injuries and strokes. The Infrascanner is designed to effectively and accurately detect intracranial bleeding, enabling clinicians to identify patients who require immediate referral for further imaging, such as CT scans, and potential neurosurgical intervention. This innovative device has been FDA-cleared and CE marked, demonstrating its compliance with rigorous safety and efficacy standards. The Infrascanner has been deployed in various settings, including military field hospitals, emergency rooms, and intensive care units, highlighting its versatility and importance in urgent medical situations.

The technology behind the Infrascanner was developed by Dr. Britton Chance and Dr. Claudia Robertson, who successfully tested the NIR system in a clinical study involving 305 patients. The device addresses a critical need in trauma care, particularly given that a significant percentage of combat injuries involve head trauma, with many resulting in treatable brain hematomas. By providing a rapid and non-invasive means of assessing brain injuries, the Infrascanner enhances the ability of medical professionals to triage patients effectively, ultimately improving outcomes for those suffering from head injuries.

United States

InfraScan, Inc. is a medical device company that focuses on developing, commercializing, and distributing hand-held diagnostic devices for head injury and stroke assessment based on near infrared (NIR) technology. InfraScan Inc.'s patented NIR technology for diagnosing brain hematomas enables neurosurgeons to effectively, conveniently, and accurately detect intracranial bleeding in patients with Head Trauma.

InfraScan

Company Details